Gene Bridges granted Patents in Japan and Mexico for Recombineering Technology

01-Aug-2008

Gene Bridges GmbH announced that it has been granted patents in Japan and in Mexico relating to the Company's recombineering technology. The Japanese Patent (No. 4139561) was entitled "Novel DNA cloning Method" while the Mexican Patent (No. 252928) was entitled "Methods and compositions for directed cloning and subcloning using homologous recombination". Both patents broadly cover the major areas of Gene Bridges' RED/ET Recombination technology. This is the same technology that is already covered by issued patents in the USA, EU, Korea and Israel.

Gary Stevens, CEO of Gene Bridges GmbH, commented: 'Japan is a very important and growing market for us and this patent marks an important step in the international recognition of Red/ET while the Mexican patent strengthens our already strong position in North America.These important milestones in two new markets demonstrates that recombineering is the technology of choice in DNA engineering and is used worldwide in industry and academia.' Gene Bridges is represented in Japan by the company Funakoshi.

Red/ET is a method for DNA engineering. Recombineering with Red/ET allows cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs or the E.coli chromosome, according to the company.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances